RE:RE:RE:RE:RE:RE:Partnership coming $ 640 million to $740 million. Roche's is a multi billion $ concern which develops a bladder cancer drug called
IMVIGOR (
Phase II IMHO, Phase III enrolling, years apart, correct me if i'm wrong).
Telesta has a Phase III bladder cancer drug with a registered trademark called
IMVYON, shortly before marketlaunch (if all goes well, ofcourse).
If you're in Roche's management, would you mind? I would!
Maybe choosing a similar name it's Telesta's way to doubleknock on Roche's Head.
Maybe this get's more attraction by other's, too.
BO cames in mind.
But it's just my opinion.
Thanks for asking and to conspiTheory for letting me think.